Bacterial contamination during cold organ preservation occurs without major complications. However, with organ preservation steering towards (sub)normothermic temperatures, bacterial contamination may be detrimental. Since limited evidence exists to support the choice of antibiotic, this study aimed to determine eff ective antibiotic prophylactis for (sub)normothermic preservation. Accordingly, we tested whether S.
Introduction
A persistent donor organ shortage has stimulated the development of novel, more advanced organ preservation techniques to increase donor organ availability. Expansion of the donor pool by including extended criteria donor organs requires preservation techniques that minimize preservation injury. 1 Hence, organ preservation is steering away from static cold storage, initially to hypothermic (4 °C) machine perfusion preservation, followed by subnormothermic (28 °C) and even normothermic (37 °C) machine perfusion ((S)NMP). 2 Nutrient-rich preservation solutions and extended preservation times increase the risk of bacterial graft contamination and pose a threat to the graft and the immunocompromised recipient. Graft or preservation solution contamination has a reported clinical incidence of 8 -62.5 % in transplantations that employ hypothermic preservation, of which up to 17.8 % involves high-risk microorganisms. [3] [4] [5] [6] [7] [8] Although graft contamination after hypothermic preservation usually does not result in adverse outcomes, contamination may be detrimental at warmer conditions and in nutrient-rich preservation solutions, as these provide a fecund environment for bacterial growth. 4, 6 An review of recent literature (1990-2012) for studies employing renal or liver (S)
NMP revealed that only 14 of 33 recently published papers addressed antibiotic prophylaxis,
indicating that antibiotic addition is omitted by many, or grossly underreported. [9] [10] [11] [12] [13] Tolboom et al.
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, employing a cell culture medium for perfusion, based their choice of penicillin/ streptomycin on successful in vitro work (personal communication). High dose cephalosporin (1500 μg/ mL) was used most frequently to prime the perfusion circuit 15 or as a bolus (1000 μg/ mL) per 24 h of perfusion. 16 Cephalosporins are eff ective against many of the preservation-associated microorganisms in the absence of antibiotic-induced adverse eff ects.
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T h e u s e o f c e p h a l o s p o r i n s d u r i n g ( S ) N M P h a s n o t y e t b e e n e x a m i n e d a n d no guidelines or recommendations for antibiotic prophylaxis during (S)NMP exist. The antibiotic choice must be rationalized by optimal prevention of bacterial growth without causing additional damage to the preserved organ.
This study aimed to establish a suitable antibiotic prophylaxis regime in renal (S) NMP. To this end, in vitro models were employed using various Staphylococcus epidermidis 
Effi cacy of ceftriaxone and cefazolin
The bacteriostatic eff ect of ceftriaxone and cefazolin on S. epidermidis RP62a in PS was assessed at ceftriaxone (Fresenius Kabi, Bad Homburg, Germany) or cefazolin (Sandoz, Kundl, Austria) concentrations of 0, 75, 150, 300, 600, or 1000 μg/ mL, by measuring the OD 620nm after 0, 2, 4, 6, 8, 12, 24, and 48 h of incubation at 37 °C. In addition, bactericidal activity was determined by quantitative culture.
Dose-response of cefazolin under (sub)normothermic conditions
Cefazolin's bactericidal capacity against the S. epidermidis and S. aureus strains was assessed during in vitro (sub)normothermic incubation in PS. To this end, 0, 300, or 1000 μg/ mL cefazolin was added to microtiter plates, prepared as described above. Plates were incubated for 68 h at 37 °C or 20 h at 28 °C, followed by 48 h at 37 °C. CFU/ mL were determined by quantitative culture of the samples.
Washout of cefazolin during organ reperfusion was simulated in vitro to assess its eff ect on residual bacterial growth. Cefazolin was added at a concentration of 0, 300, and 1000 μg/ mL to 5 mL of S. epidermidis RP62a-inoculated PS. After 20 h of incubation at 28 °C (shaking), the cefazolin was removed by washing the bacteria three times in 5 mL PS (15,000 ×g, 10 min, 20 °C) and resuspending the pelleted bacteria in an equal volume of PS as used for the fi rst incubation period. These suspensions were subsequently incubated for another 24 h at 37 °C. Bacterial growth was determined by quantitative culture and compared to suspensions in which cefazolin had not been washed out. Next, an equal volume of WE containing 20 % fresh DMSO was slowly added to the cell suspensions up to a fi nal volume of 1.8 mL, after which the cell suspensions were stored in liquid nitrogen.
Prior to use, cells were thawed and washed twice with 18 mL of 20 % FCSenriched WE (400 ×g, 10 min, 4 °C). The cell pellet was resuspended in 5 mL ECGM and cultured as described. Cells were used after the third passage had become confl uent.
Cell viability and caspase induction
PKEC were seeded in fi bronectin (Sigma-Aldrich, St. Louis, MO)-coated 24-wells culture plates (Corning Incorporated, Corning, NY) and cultured in ECGM. Upon reaching confl uence, cell viability and caspase 3 and 7 levels were determined after 0 h and 8 h.
Cell viability was determined with a tetrazolium salt assay (WST-1, Roche). The medium was aspirated, the wells incubated in WST reagent (300 µL per well) and incubated for 30 min at 37 °C. The absorbance was measured using a Synergy HT microplate reader (λ abs = 440 nm, BioTek, Winooski, VT).
Caspase 3 and 7 levels were determined using a fl uorochrome inhibitor of caspase (FLICA) kit (reference# A20173, AbD Serotec, Oxford, UK) according to the manufacturer's instructions (λ ex = 575 nm, λ em = 620 nm).
WST and caspase data were normalized to protein content (Bradford protein assay, BioRad, Hercules, CA) and expressed as a percentage of the mean of the 0-h values.
Statistical analysis
Statistical analysis of diff erences in bacterial concentrations was performed using a 2-way analysis of variance (ANOVA) with a Bonferroni post-hoc test between groups, and unpaired-sample Student's t-test between time points within one group.
Toxicity data were analyzed using a Kruskal-Wallis test with Dunn's multiple comparison test (α= 0.05). A P-value of <0.05 was considered statistically signifi cant.
Results

Bacterial growth in preservation solutions
Signifi cant S. epidermidis RP62a growth was observed in both TSB and PS.
However, a ten-fold larger increase in CFU/ mL was observed in TSB after 24 h (P<0.001, Figure 1 ). After 20 h of incubation at 28 °C and subsequently for 48 h at 37 °C, growth of all S. epidermidis and S. aureus strains occurred in both TSB ( Figure 2A ) and PS ( Figure 2B ). In PS, however, the numbers of CFU of S. aureus 8325-4 and its SCV strain I10 decreased until 44 h, but increased to numbers similar to those of the other strains at 68 h. No diff erences in growth in TSB and PS were observed between the wild type and corresponding SCV strains. In general, the strains grew to higher numbers of CFU in TSB than in PS. While there was growth of S. epidermidis RP62a in TSB and PS, the numbers of CFU decreased during the total 68-h incubation in HTK, UW solution, or Belzer-MPS ( Figure 2C ). Growth kinetics of S. epidermidis RP62a in Polysol (PS) and tryptic soy broth (TSB) during 24 h at 37 °C.
* indicates a signifi cant diff erence from TSB. 
Effi cacy of cefazolin and ceftriaxone
In the absence of antibiotics, S. epidermidis RP62a showed signifi cant growth during the fi rst 12 h (P<0.001). A slightly increased OD 620nm was observed after 48-h incubation in TSB with 75 μg/ mL ceftriaxone (NS). In all other incubations the antibiotic inhibited the growth of the bacteria. Based on spectrophotometric measurements, cefazolin had superior bactericidal effi cacy over ceftriaxone, which was confi rmed by quantitative plating (Figure 3A / B). After 2 and 12 h, 75 μg/ mL of cefazolin was suffi cient to reduce the numbers of CFU/ mL of S. epidermidis RP62a below the detection limit. In contrast, ceftriaxone required a concentration of 1000 and 300 μg/mL after 2 and 12 h, respectively, to obtain a similar bactericidal eff ect. Eff ect of the removal of cefazolin on continued growth of S. epidermidis RP62a.
S. epidermidis RP62a were exposed to the indicated cefazolin concentrations for 20 h at 28 °C, after an temperature increase to 37 °C without any changes in the solution (solid lines), or after replacement of the cefazolin-containing solution with antibiotic-free solution.
Dose-response of cefazolin under (sub)normothermic conditions
Incubation of S. epidermidis and S. aureus strains at 37 °C in PS with cefazolin led to a complete elimination of most strains (Figure 4) . A 1000-μg/ mL concentration decreased the bacterial concentration to below the detection limit at t=44 h, while 300 μg/ mL led to a slower elimination and was insuffi cient to eradicate the SCV S. epidermidis strain 6455-I. To mimic subnormothermic preservation and normothermic post-transplantation conditions, S. epidermidis was incubated in PS for 20 h at 28 °C and subsequently for 24 h at 37 °C. The bactericidal eff ect was less prominent at 28 °C compared to 37 °C, but subsequent warming to 37 °C greatly enhanced the eff ect ( Figure 5 ). Again, a concentration of 1000 μg/ mL was able to consistently reduce bacterial numbers to undetectable values by t= 44 h, while 300 μg/ mL led to slower and incomplete eradication.
Removal of the cefazolin prior to warming from 28 °C to 37 °C allowed S.
epidermidis RP62a growth in the suspensions to which 300 μg/ mL had initially been added ( Figure 6 ). However, an increase in CFU/mL was deterred up to 12 h compared to the antibiotic-free control. Only an initial cefazolin concentration of 1000 μg/ mL was capable of reducing bacterial CFU in PS to below the limit of detection after cefazolin had been removed. * indicates a signifi cant decrease in caspase 3 and 7 levels from t= 0 h compared to 0 μg/ mL.
Cytotoxicity of cefazolin to porcine kidney endothelial cells
After 8-h incubation, the change in PKEC viability relative to t = 0 h did not diff er signifi cantly between the 0 μg/ mL and the 1000 μg/ mL cefazolin concentrations (21.1 % and 26.5 % increase) and all other concentrations ( Figure 7 ). Furthermore, caspases 3 and 7 activation remained absent regardless of the cefazolin concentration. Interestingly, incubation in 300 μg/ mL cefazolin was associated with a reduced extent of apoptosis compared to control (0 μg/ mL) after 8 h (-24.8 % and -4.3 %, respectively, P <0.05).
Accordingly, no evidence of cytotoxicity of high-dose cefazolin was observed in PKEC.
Discussion
This is the fi rst study to describe the growth of S. epidermidis and S. aureus wild type and SCV strains in diff erent preservation media during (sub)normothermic conditions, and their susceptibility to antibiotic prophylaxis. The main fi ndings were: 1) bacterial growth in (S)NMP preservation solutions is a risk at (sub)normothermic conditions, 2) in the nutrientrich PS, the bactericidal effi cacy of cefazolin is greater than that of ceftriaxone, 3) 1000 μg/ mL of cefazolin is bactericidal during subnormothermic and at normothermic incubation, even after cefazolin removal, and 4) 1000 μg/ mL cefazolin is non-toxic to PKEC in vitro.
High rates of bacterial contamination in organ preservation solutions have always been a reason for concern. While hypothermia appears to prevent bacterial growth and limit infectious complications 4 , bacteria remain viable after hypothermic preservation, even in the presence of penicillin and trimethoprim/ sulfamethoxazole. 23 With the current preservation techniques moving from static hypothermic storage to dynamic (sub) normothermic techniques, more aggressive antimicrobial prophylaxis is required to ensure sterility of nutrient-rich preservation solutions and the ex vivo preserved organ. 24 We found that HTK and UW did not support bacterial growth under (sub)normothermic conditions, which is likely due to the absence of nutritional constituents for bacteria in these solutions. 25 PS, developed primarily for warm preservation, did facilitate signifi cant bacterial growth, implying that a potential risk for other novel, (S)NMP preservation solutions exists as well. 26, 27 N e w i n s i g h t s i n t o t h e n a t u r e o f t h e m i c r o o r g a n i s m s r e s p o n s i b l e f o r s i g n i fi c a n t infections should be taken into account when determining appropriate prophylaxis. In this respect, SCV are associated with a slow growth rate, atypical colony morphology, and aberrant biochemical properties that are thought to make them less susceptible to many antibiotics and therefore, responsible for persistent and latent infections. 18 S. aureus 8325-4 and its SCV have been shown to be equally infective and comparably susceptible to cephapirin. 28 Accordingly, our fi ndings show similar effi cacy of cefazolin across diff erent strains and their respective SCV, supporting the broad antimicrobial coverage of cefazolin.
Furthermore, the continuing bactericidal eff ect after removal of the antibiotic appears to be instrumental in preventing latent infections. Prophylactic addition of antimicrobial agents to preservation solutions has been common practice for decades. 23 However, current experimental and clinical preservation protocols frequently neglect antibiotic prophylaxis, and, where reported, do not address sterility and antibiotic toxicity, despite high contamination rates and nephrotoxicity, respectively. It is likely that this stems from the absence of an evidence-based recommendation. Our results provide compelling in vitro rationalization for the use of high-dose cefazolin, which is effi cacious against the major contaminating staphylococcal species and even against their SCV. When combined with bacterial culturing according to standard operating procedures, high dose cefazolin could help minimize infectious complication following (S)NMP.
In conclusion, a 1000 μg/ mL cefazolin dose is eff ective against multiple S.
epidermidis and S. aureus strains and their SCV at 28 °C and 37 °C in PS, and was non-toxic for PKEC. It is therefore recommended to use high-dose cefazolin as antibiotic prophylaxis during warm kidney preservation with Polysol.
